EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Inhibition of calcium/calmodulin-dependent protein kinase kinase β and calcium/calmodulin-dependent protein kinase IV is detrimental in cerebral ischemia



Inhibition of calcium/calmodulin-dependent protein kinase kinase β and calcium/calmodulin-dependent protein kinase IV is detrimental in cerebral ischemia



Stroke 44(9): 2559-2566



Elevation of intracellular calcium was traditionally thought to be detrimental in stroke pathology. However, clinical trials testing treatments that block calcium signaling have failed to improve outcomes in ischemic stroke. Emerging data suggest that calcium may also trigger endogenous protective pathways after stroke. Calcium/calmodulin-dependent protein kinase kinase (CaMKK) is a major kinase activated by rising intracellular calcium. Compelling evidence has suggested that CaMKK and its downstream kinase CaMK IV are critical in neuronal survival when cells are under ischemic stress. We examined the functional role of CaMKK/CaMK IV signaling in stroke. We used a middle cerebral artery occlusion model in mice. Our data demonstrated that pharmacological and genetic inhibition of CaMKK aggravated stroke injury. Additionally, deletion of CaMKK β, one of the 2 CaMKK isoforms, reduced CaMK IV activation, and CaMK IV deletion in mice worsened stroke outcome. Finally, CaMKK β or CaMK IV knockout mice had exacerbated blood-brain barrier disruption evidenced by increased hemorrhagic transformation and activation of matrix metalloproteinase. We observed transcriptional inactivation including reduced levels of histone deacetylase 4 phosphorylation in mice with CaMKK β or CaMK IV deletion after stroke. Our data have established that the CaMKK/CaMK IV pathway is a key endogenous protective mechanism in ischemia. Our results suggest that this pathway serves as an important regulator of blood-brain barrier integrity and transcriptional activation of neuroprotective molecules in stroke.

(PDF emailed within 0-6 h: $19.90)

Accession: 053865561

Download citation: RISBibTeXText

PMID: 23868268

DOI: 10.1161/STROKEAHA.113.001030



Related references

Human calcium-calmodulin dependent protein kinase I: cDNA cloning, domain structure and activation by phosphorylation at threonine-177 by calcium-calmodulin dependent protein kinase I kinase. Embo Journal 14(15): 3679-3686, 1995

Effects of selective inhibition of protein kinase C, cyclic AMP-dependent protein kinase, and calcium-calmodulin-dependent protein kinase on neurite development in cultured rat hippocampal neurons. International Journal of Developmental Neuroscience 11(3): 357-368, 1993

A purine analog kinase inhibitor, calcium/calmodulin-dependent protein kinase II inhibitor 59, reveals a role for calcium/calmodulin-dependent protein kinase II in insulin-stimulated glucose transport. Endocrinology 148(1): 374-385, 2006

Characterization of a Ca2+/calmodulin-dependent protein kinase cascade. Molecular cloning and expression of calcium/calmodulin-dependent protein kinase kinase. Journal of Biological Chemistry 270(33): 19320-4, 1995

Calcium calmodulin 4 is the active calmodulin calcium species activating the calcium dependent calmodulin dependent protein kinase of cardiac sarcoplasmic reticulum in the regulation of the calcium pump. Biochimica et Biophysica Acta 773(2): 197-206, 1984

Phosphorylation of P1, a high mobility group-like protein, catalyzed by casein kinase II, protein kinase C, cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II. Febs Letters 258(1): 106-108, 1989

A calcium/calmodulin-binding serine/threonine protein kinase homologous to the mammalian type II calcium/calmodulin-dependent protein kinase is expressed in plant cells. Plant Physiology 101(4): 1381-1384, 1993

Nitric oxide synthase regulatory sites phosphorylation by cyclic amp dependent protein kinase protein kinase c and calcium calmodulin protein kinase identification of flavin and calmodulin binding sites. Journal of Biological Chemistry 267(16): 10976-10981, 1992

Calcium calmodulin dependent protein kinase enriched in cerebellar granule cells identification of a novel neuronal calmodulin dependent protein kinase. Journal of Biological Chemistry 264(10): 5866-5875, 1989

Block of calcium influx during ischemia inhibits down regulation of calcium-calmodulin-dependent protein kinase II and protein kinase C. Society for Neuroscience Abstracts 18(1-2): 1589, 1992

Growth inhibition of human gastric adenocarcinoma cells in vitro by STO-609 is independent of calcium/calmodulin-dependent protein kinase kinase-beta and adenosine monophosphate-activated protein kinase. American Journal of Translational Research 8(2): 1164-1171, 2016

Site-specific phosphorylation of the purified receptor for calcium-channel blockers by cAMP- and cGMP-dependent protein kinases, protein kinase C, calmodulin-dependent protein kinase II and casein kinase II. European Journal of Biochemistry 178(2): 535-542, 1988

Ethanol has no effect on camp dependent protein kinase protein kinase c or calcium calmodulin dependent protein kinase ii stimulated phosphorylation of highly purified substrates in vitro. Alcoholism Clinical & Experimental Research 15(6): 1040-1044, 1991

Enzymatic detection of a calcium calmodulin dependent protein kinase in rinm5f cells similar to calcium calmodulin kinase type ii. Hormone & Metabolic Research 24(2): 95, 1992

Role of calcium in inactivation of calcium/calmodulin dependent protein kinase II after cerebral ischemia. Journal of the Neurological Sciences 113(1): 31-37, 1992